 Dexamethasone
"Dexamethasone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anti-inflammatory 9-fluoro-glucocorticoid.
| Descriptor ID |
D003907
|
| MeSH Number(s) |
D04.808.745.432.769.344 D04.808.908.238
|
| Concept/Terms |
Decaject-L.A.- Decaject-L.A.
- Decaject L.A.
- Merz Brand 2 of Dexamethasone
Decameth- Decameth
- Foy Brand of Dexamethasone
Decaspray- Decaspray
- Merck Brand of Dexamethasone
Dexpak- Dexpak
- ECR Brand of Dexamethasone
Maxidex- Maxidex
- Alcon Brand of Dexamethasone
Decaject- Decaject
- Merz Brand 1 of Dexamethasone
Dexasone- Dexasone
- ICN Brand of Dexamethasone
|
Below are MeSH descriptors whose meaning is more general than "Dexamethasone".
Below are MeSH descriptors whose meaning is more specific than "Dexamethasone".
This graph shows the total number of publications written about "Dexamethasone" by people in this website by year, and whether "Dexamethasone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1982 | 0 | 2 | 2 | | 1984 | 0 | 1 | 1 | | 1985 | 1 | 1 | 2 | | 1987 | 1 | 0 | 1 | | 1988 | 3 | 1 | 4 | | 1989 | 1 | 2 | 3 | | 1990 | 0 | 1 | 1 | | 1991 | 1 | 0 | 1 | | 1992 | 1 | 1 | 2 | | 1993 | 1 | 0 | 1 | | 1994 | 1 | 2 | 3 | | 1995 | 4 | 1 | 5 | | 1996 | 6 | 0 | 6 | | 1997 | 2 | 6 | 8 | | 1998 | 0 | 3 | 3 | | 1999 | 0 | 5 | 5 | | 2000 | 3 | 5 | 8 | | 2001 | 3 | 2 | 5 | | 2002 | 2 | 1 | 3 | | 2003 | 7 | 3 | 10 | | 2004 | 1 | 1 | 2 | | 2005 | 1 | 3 | 4 | | 2006 | 2 | 3 | 5 | | 2007 | 3 | 7 | 10 | | 2008 | 5 | 3 | 8 | | 2009 | 1 | 4 | 5 | | 2010 | 3 | 6 | 9 | | 2011 | 2 | 9 | 11 | | 2012 | 7 | 9 | 16 | | 2013 | 4 | 4 | 8 | | 2014 | 3 | 10 | 13 | | 2015 | 5 | 3 | 8 | | 2016 | 2 | 5 | 7 | | 2017 | 0 | 4 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Dexamethasone" by people in Profiles.
-
Hixon AM, Clarke P, Tyler KL. Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis. J Infect Dis. 2017 Dec 05; 216(10):1245-1253.
-
Sasse SK, Kadiyala V, Danhorn T, Panettieri RA, Phang TL, Gerber AN. Glucocorticoid Receptor ChIP-Seq Identifies PLCD1 as a KLF15 Target that Represses Airway Smooth Muscle Hypertrophy. Am J Respir Cell Mol Biol. 2017 08; 57(2):226-237.
-
Winick N, Devidas M, Chen S, Maloney K, Larsen E, Mattano L, Borowitz MJ, Carroll A, Gastier-Foster JM, Heerema NA, Willman C, Wood B, Loh ML, Raetz E, Hunger SP, Carroll WL. Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group. J Clin Oncol. 2017 Aug 01; 35(22):2527-2534.
-
Davis C, Hackett P. Advances in the Prevention and Treatment of High Altitude Illness. Emerg Med Clin North Am. 2017 May; 35(2):241-260.
-
Blanton E, Lamvu G, Patanwala I, Barron KI, Witzeman K, Tu FF, As-Sanie S. Non-opioid pain management in benign minimally invasive hysterectomy: A systematic review. Am J Obstet Gynecol. 2017 06; 216(6):557-567.
-
Palumbo A, Chanan-Khan A, Weisel K, Nooka AK, Masszi T, Beksac M, Spicka I, Hungria V, Munder M, Mateos MV, Mark TM, Qi M, Schecter J, Amin H, Qin X, Deraedt W, Ahmadi T, Spencer A, Sonneveld P. Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma. N Engl J Med. 2016 Aug 25; 375(8):754-66.
-
Sasse SK, Altonsy MO, Kadiyala V, Cao G, Panettieri RA, Gerber AN. Glucocorticoid and TNF signaling converge at A20 (TNFAIP3) to repress airway smooth muscle cytokine expression. Am J Physiol Lung Cell Mol Physiol. 2016 Aug 01; 311(2):L421-32.
-
Rytting ME, Jabbour EJ, Jorgensen JL, Ravandi F, Franklin AR, Kadia TM, Pemmaraju N, Daver NG, Ferrajoli A, Garcia-Manero G, Konopleva MY, Borthakur G, Garris R, Wang S, Pierce S, Schroeder K, Kornblau SM, Thomas DA, Cortes JE, O'Brien SM, Kantarjian HM. Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen. Am J Hematol. 2016 Aug; 91(8):819-23.
-
Gregory DG. New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson Syndrome. Ophthalmology. 2016 08; 123(8):1653-1658.
-
Lust JA, Lacy MQ, Zeldenrust SR, Witzig TE, Moon-Tasson LL, Dinarello CA, Donovan KA. Reduction in C-reactive protein indicates successful targeting of the IL-1/IL-6 axis resulting in improved survival in early stage multiple myeloma. Am J Hematol. 2016 Jun; 91(6):571-4.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|